<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01965665</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00046972</org_study_id>
    <nct_id>NCT01965665</nct_id>
  </id_info>
  <brief_title>Advancing the Standard of Care for Pin Site Care</brief_title>
  <official_title>Advancing the Standard of Care for Pin Site Care: Prospective Single Center Study Using Medihoney HCS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to prospectively evaluate the effect of Active Leptospermum
      honey utilizing the MediHoney HCS dressing, on the occurrence of PIN site infections, and
      also to see if the use of MediHoney HCS reduces the frequency of dressing changes compared to
      published reports of routine standard pin site care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Up to 20 Diabetic Mellitus patients undergoing Open Reduction External Fixation (OREF) for
      foot and/or ankle fusions, fracture repair, or osteotomy will be enrolled to receive weekly
      Medihoney pin site care until frame removal. Standard size dressings and application
      technique will be used at each pin site with prefabricated materials. No procedures, tests or
      interventions will be performed exclusively for research purposes or more frequently than the
      standard of care. Upon completion of the study, pin sites sepsis rates will be compared to
      published reports for standard pin site care.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Number of Pin Sites</measure>
    <time_frame>Day of surgical intervention approximately 3hrs.</time_frame>
    <description>total number of pin sites for all patients enrolled</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Patients With Pin Site Infection</measure>
    <time_frame>weekly from baseline until frame removal, up to 16 weeks</time_frame>
    <description>Patients will be assessed weekly for pin site infection up until frame removal.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Sepsis Rate</measure>
    <time_frame>weekly from baseline until frame removal, up to 16 weeks</time_frame>
    <description>Patients will be assessed weekly for sepsis or until frame is removed.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Open Reduction External Fixation</condition>
  <arm_group>
    <arm_group_label>Medihoney HCS dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>weekly Medihoney pin site care until frame removal. Standard size dressings and application technique will be used at each pin site with prefabricated materials.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MediHoney HCS dressing</intervention_name>
    <arm_group_label>Medihoney HCS dressing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A signed and dated informed consent has been obtained from the subject.

          -  Subject is able and willing to comply with study procedures.

          -  Subject is 18 years of age or older.

          -  Type I or II Diabetes

          -  Albumin &gt;2.5

          -  A1C&lt;12 or average fasting levels &lt;200

          -  ABI &gt; .6 or biphasic pedal vessels by Doppler

          -  Charcot arthropathy of lower extremity

               -  Foot/ankle deformity

               -  Foot/ankle fracture

          -  Subject will undergo an Open Reduction with External Fixation (OREF).

        Exclusion Criteria:

          -  A1C &gt; 12

          -  ABI &lt; .6 or monophasic pedal pulses on Doppler

          -  Recent (&lt;2 months) or ongoing bone infection based on radiograph or scan

          -  Cellulitis of lower extremity within the last 2 months based on clinical exam and/or
             laboratory markers

          -  Honey or honey based allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Kerzner, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Duke University Medical Center/Duke South Clinics/3J</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2013</study_first_submitted>
  <study_first_submitted_qc>October 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 18, 2013</study_first_posted>
  <results_first_submitted>June 9, 2016</results_first_submitted>
  <results_first_submitted_qc>September 13, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 31, 2016</results_first_posted>
  <last_update_submitted>September 13, 2016</last_update_submitted>
  <last_update_submitted_qc>September 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Surgical Intervention</keyword>
  <keyword>Honey</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Medihoney HCS Dressing</title>
          <description>weekly Medihoney pin site care until frame removal. Standard size dressings and application technique will be used at each pin site with prefabricated materials.
MediHoney HCS dressing</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Medihoney HCS Dressing</title>
          <description>weekly Medihoney pin site care until frame removal. Standard size dressings and application technique will be used at each pin site with prefabricated materials.
MediHoney HCS dressing</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Number of Pin Sites</title>
        <description>total number of pin sites for all patients enrolled</description>
        <time_frame>Day of surgical intervention approximately 3hrs.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medihoney HCS Dressing</title>
            <description>weekly Medihoney pin site care until frame removal. Standard size dressings and application technique will be used at each pin site with prefabricated materials.
MediHoney HCS dressing</description>
          </group>
        </group_list>
        <measure>
          <title>Total Number of Pin Sites</title>
          <description>total number of pin sites for all patients enrolled</description>
          <units>total number of pin sites</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="244"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients With Pin Site Infection</title>
        <description>Patients will be assessed weekly for pin site infection up until frame removal.</description>
        <time_frame>weekly from baseline until frame removal, up to 16 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Medihoney HCS Dressing</title>
            <description>weekly Medihoney pin site care until frame removal. Standard size dressings and application technique will be used at each pin site with prefabricated materials.
MediHoney HCS dressing</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Pin Site Infection</title>
          <description>Patients will be assessed weekly for pin site infection up until frame removal.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Sepsis Rate</title>
        <description>Patients will be assessed weekly for sepsis or until frame is removed.</description>
        <time_frame>weekly from baseline until frame removal, up to 16 weeks</time_frame>
        <population>Data not collected</population>
        <group_list>
          <group group_id="O1">
            <title>Medihoney HCS Dressing</title>
            <description>weekly Medihoney pin site care until frame removal. Standard size dressings and application technique will be used at each pin site with prefabricated materials.
MediHoney HCS dressing</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Sepsis Rate</title>
          <description>Patients will be assessed weekly for sepsis or until frame is removed.</description>
          <population>Data not collected</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>baseline until frame removal, up to 16 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Medihoney HCS Dressing</title>
          <description>weekly Medihoney pin site care until frame removal. Standard size dressings and application technique will be used at each pin site with prefabricated materials.
MediHoney HCS dressing</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>GI infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>osteotomy site infection (not pin site)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michael Kerzner, DMP</name_or_title>
      <organization>Duke University Medical Center</organization>
      <phone>919-613-4449</phone>
      <email>michael.kerzner@duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

